Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Tetzlaff

Showing results (91-100 of 224) with videos related to

Pageof 23
Sort By:
Human Pathology|March 22, 2016
BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expressionKumaran Mudaliar, Michael T Tetzlaff, Madeleine Duvic, et al.
The American Journal of Dermatopathology|April 5, 2016
Cutaneous Metastasis of a Mucoepidermoid Carcinoma of the Pancreas: First Reported CasePrasamsa Pandey, Rami N Al-Rohil, Jennifer B Goldstein, et al.
Annals of Clinical and Laboratory Science|April 22, 2016
Role of Radiotherapy in Aggressive Digital Papillary AdenocarcinomaLaurence Feldmeyer, Victor G Prieto, Doina Ivan, et al.
Journal for Immunotherapy of Cancer|January 25, 2017
Erratum to: A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1Marc Uemura, Faisal Fa'ak, Cara Haymaker, et al.
The American Journal of Dermatopathology|February 26, 2019
Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case SeriesPhyu P Aung, Priyadharsini Nagarajan, Michael T Tetzlaff, et al.
Cancer Medicine|July 3, 2015
Demographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registriesIvan V Litvinov, Michael T Tetzlaff, Elham Rahme, et al.
Journal for Immunotherapy of Cancer|September 24, 2016
A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1Marc Uemura, Faisal Fa'ak, Cara Haymaker, et al.
JAMA Ophthalmology|February 28, 2020
Association of T and N Categories of the American Joint Commission on Cancer, 8th Edition, With Metastasis and Survival in Patients With Orbital SarcomaHo-Seok Sa, Maria Laura Rubin, Jing Ning, et al.
Journal of Cutaneous Pathology|November 11, 2018
Angiotropism in recurrent cutaneous squamous cell carcinoma: Implications for regional tumor recurrence and extravascular migratory spreadFaysal Fedda, Michael R Migden, Jonathan L Curry, et al.
Journal of Cutaneous Pathology|June 22, 2020
Cutaneous adnexal carcinosarcoma: Immunohistochemical and molecular evidence of epithelial mesenchymal transitionDongHyang Kwon, Shira Ronen, Alessio Giubellino, et al.
Pageof 23

Showing results (91-100 of 224) with videos related to

Sort By:
Pageof 23
Human Pathology|March 22, 2016
BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expressionKumaran Mudaliar, Michael T Tetzlaff, Madeleine Duvic, et al.
The American Journal of Dermatopathology|April 5, 2016
Cutaneous Metastasis of a Mucoepidermoid Carcinoma of the Pancreas: First Reported CasePrasamsa Pandey, Rami N Al-Rohil, Jennifer B Goldstein, et al.
Annals of Clinical and Laboratory Science|April 22, 2016
Role of Radiotherapy in Aggressive Digital Papillary AdenocarcinomaLaurence Feldmeyer, Victor G Prieto, Doina Ivan, et al.
Journal for Immunotherapy of Cancer|January 25, 2017
Erratum to: A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1Marc Uemura, Faisal Fa'ak, Cara Haymaker, et al.
The American Journal of Dermatopathology|February 26, 2019
Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case SeriesPhyu P Aung, Priyadharsini Nagarajan, Michael T Tetzlaff, et al.
Cancer Medicine|July 3, 2015
Demographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registriesIvan V Litvinov, Michael T Tetzlaff, Elham Rahme, et al.
Journal for Immunotherapy of Cancer|September 24, 2016
A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1Marc Uemura, Faisal Fa'ak, Cara Haymaker, et al.
JAMA Ophthalmology|February 28, 2020
Association of T and N Categories of the American Joint Commission on Cancer, 8th Edition, With Metastasis and Survival in Patients With Orbital SarcomaHo-Seok Sa, Maria Laura Rubin, Jing Ning, et al.
Journal of Cutaneous Pathology|November 11, 2018
Angiotropism in recurrent cutaneous squamous cell carcinoma: Implications for regional tumor recurrence and extravascular migratory spreadFaysal Fedda, Michael R Migden, Jonathan L Curry, et al.
Journal of Cutaneous Pathology|June 22, 2020
Cutaneous adnexal carcinosarcoma: Immunohistochemical and molecular evidence of epithelial mesenchymal transitionDongHyang Kwon, Shira Ronen, Alessio Giubellino, et al.
Pageof 23